Nanjing Sinolife United Company Limited (3332.HK)
HKD 0.58
(1.75%)
HKD 0.58
(1.75%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 127.35 Million CNY | 12.51% |
| 2022 | 113.18 Million CNY | 89.06% |
| 2021 | 59.86 Million CNY | -31.48% |
| 2020 | 87.36 Million CNY | -33.6% |
| 2019 | 131.57 Million CNY | -4.26% |
| 2018 | 137.42 Million CNY | -14.08% |
| 2017 | 159.94 Million CNY | 55.5% |
| 2016 | 102.85 Million CNY | 60.6% |
| 2015 | 64.04 Million CNY | 100.46% |
| 2014 | 31.95 Million CNY | 14.67% |
| 2013 | 27.86 Million CNY | 38.5% |
| 2012 | 20.11 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 138.99 Million CNY | 0.0% |
| 2024 Q1 | 138.99 Million CNY | 9.15% |
| 2023 Q3 | 127.35 Million CNY | 16.82% |
| 2023 Q4 | 127.35 Million CNY | 0.0% |
| 2023 FY | 127.35 Million CNY | 12.51% |
| 2023 Q1 | 109.01 Million CNY | -3.69% |
| 2023 Q2 | 109.01 Million CNY | 0.0% |
| 2022 Q3 | 113.18 Million CNY | 100.64% |
| 2022 Q2 | 56.41 Million CNY | 0.0% |
| 2022 Q4 | 113.18 Million CNY | 0.0% |
| 2022 Q1 | 56.41 Million CNY | -5.77% |
| 2022 FY | 113.18 Million CNY | 89.06% |
| 2021 FY | 59.86 Million CNY | -31.48% |
| 2021 Q3 | 59.86 Million CNY | 2.92% |
| 2021 Q2 | 58.17 Million CNY | 0.0% |
| 2021 Q4 | 59.86 Million CNY | 0.0% |
| 2021 Q1 | 58.17 Million CNY | -33.42% |
| 2020 FY | 87.36 Million CNY | -33.6% |
| 2020 Q1 | 94.19 Million CNY | -28.41% |
| 2020 Q2 | 94.19 Million CNY | 0.0% |
| 2020 Q3 | 87.36 Million CNY | -7.24% |
| 2020 Q4 | 87.36 Million CNY | 0.0% |
| 2019 Q3 | 131.57 Million CNY | -23.55% |
| 2019 FY | 131.57 Million CNY | -4.26% |
| 2019 Q4 | 131.57 Million CNY | 0.0% |
| 2019 Q2 | 172.11 Million CNY | 0.0% |
| 2019 Q1 | 172.11 Million CNY | 25.24% |
| 2018 Q1 | 131.51 Million CNY | -17.77% |
| 2018 FY | 137.42 Million CNY | -14.08% |
| 2018 Q4 | 137.42 Million CNY | 0.0% |
| 2018 Q3 | 137.42 Million CNY | 4.5% |
| 2018 Q2 | 131.51 Million CNY | 0.0% |
| 2017 Q4 | 159.94 Million CNY | 0.0% |
| 2017 Q1 | 186.16 Million CNY | 81.0% |
| 2017 FY | 159.94 Million CNY | 55.5% |
| 2017 Q2 | 203.63 Million CNY | 9.38% |
| 2017 Q3 | 159.94 Million CNY | -21.46% |
| 2016 Q2 | 219.63 Million CNY | 9.83% |
| 2016 Q3 | 84.9 Million CNY | -61.34% |
| 2016 FY | 102.85 Million CNY | 60.6% |
| 2016 Q1 | 199.98 Million CNY | 212.25% |
| 2016 Q4 | 102.85 Million CNY | 21.14% |
| 2015 FY | 64.04 Million CNY | 100.46% |
| 2015 Q4 | 64.04 Million CNY | 7.9% |
| 2015 Q3 | 59.35 Million CNY | -12.3% |
| 2015 Q2 | 67.68 Million CNY | 11.8% |
| 2015 Q1 | 60.53 Million CNY | 89.48% |
| 2014 FY | 31.95 Million CNY | 14.67% |
| 2014 Q1 | 15.06 Million CNY | -45.94% |
| 2014 Q2 | 15.06 Million CNY | 0.0% |
| 2014 Q4 | 31.95 Million CNY | 0.0% |
| 2014 Q3 | 31.95 Million CNY | 112.12% |
| 2013 Q1 | 20.32 Million CNY | 1.04% |
| 2013 Q3 | 27.86 Million CNY | 37.07% |
| 2013 Q2 | 20.32 Million CNY | 0.0% |
| 2013 Q4 | 27.86 Million CNY | 0.0% |
| 2013 FY | 27.86 Million CNY | 38.5% |
| 2012 Q3 | 20.11 Million CNY | 0.0% |
| 2012 FY | 20.11 Million CNY | 0.0% |
| 2012 Q4 | 20.11 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 308.05 Million HKD | 58.661% |
| Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | 88.026% |
| China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | -16.727% |
| Prosperous Future Holdings Limited | 177.1 Million HKD | 28.095% |
| Huasheng International Holding Limited | 675.58 Million HKD | 81.15% |
| Fourace Industries Group Holdings Limited | 61.8 Million HKD | -106.051% |
| Evergreen Products Group Limited | 786.46 Million HKD | 83.807% |
| EC Healthcare | 2.97 Billion HKD | 95.713% |
| Ming Fai International Holdings Limited | 772.01 Million HKD | 83.504% |
| Blue Moon Group Holdings Limited | 1.61 Billion HKD | 92.128% |
| SuperRobotics Holdings Limited | 172.27 Million HKD | 26.076% |
| Takbo Group Holdings Limited | 42.84 Million HKD | -197.206% |
| Hyfusin Group Holdings Limited | 181.34 Million HKD | 29.776% |